Use of Synthetic Biology methods to enhance and optimise production of a novel antibiotic
Use of Synthetic Biology methods to enhance and optimise production of a novel antibiotic
批准号:
131169
负责人:
金额:
$25.14万
依托单位:
依托单位国家:
英国
项目类别:
Feasibility Studies
财政年份:
2013
资助国家:
英国
项目状态:
已结题
起止时间:
2013 至 --
中文摘要
德穆里斯拥有一系列由各种不同的放线细菌产生的新型抗生素。目前,主要分子是由一种不适合大规模发酵的有机体制成的,就药理性质而言,化合物结构可能还不是最优的。我们希望确定抗生素生产者基因簇,并将其重新设计用于生产以维尼链霉菌(Streptomyces venezuelae,简称Sven)为基础的放线杆菌天然产物的优化底盘。途径工程将被用来产生主要抗生素的类似物,这将被用于促进药物优化和知识产权保护。
英文摘要
Demuris has a pipeline of novel antibiotics produced by a variety of different actinobacteria. The leading molecule is presently made by an organism that is not ideal for large scale fermentation, and the compound structure may not yet be optimal in terms of pharmacological properties. We wish to identify the antibiotic producer gene cluster and re-engineer it for production in an optimized chassis for production of actinobacterial natural products based on Streptomyces venezuelae (Sven). Pathway engineering will be used to generate analogues of the lead antibiotic, which will be used to facilitate drug optimization and IP protection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金